{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-003505","form_type":"8-K","ticker":"PURE","cik":"0001006028","company_name":"PURE BIOSCIENCE, INC.","filed_at":"2022-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.011381+00:00","generated_at":"2026-06-27T09:52:28.680111+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Pure Bioscience annual meeting: all proposals approved by wide margins","bullets":["Shareholder turnout 61.57% (53,613,132 of 87,072,963 shares outstanding).","Five director nominees elected with >96% approval: Tom Y. Lee, Ivan Chen, Tom Myers, Kristin A. Taylor, David M. Rendall.","Ratification of Weinberg & Company as auditor approved with 99.47% of votes cast.","Advisory 'say-on-pay' proposal passed with 88.41% of votes cast."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-003505","json":"https://secwatch.observer/filing/0001493152-22-003505.json","markdown":"https://secwatch.observer/filing/0001493152-22-003505.md","text":"https://secwatch.observer/filing/0001493152-22-003505.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006028/000149315222003505/0001493152-22-003505-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006028/000149315222003505/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T09:52:28.680111+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}